Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1978 • 364 citations

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1979 • 357 citations

A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MAN

1977 • 332 citations

Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme

1979 • 271 citations

Estimation of Angiotensin II Concentration in Human Plasma by Radioimmunoassay. Some Applications to Physiological and Clinical States

1971 • 262 citations

IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRIL

1979 • 180 citations

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1981 • 146 citations

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.

1980 • 145 citations

Measurement of Concentrations of Angiotensin I in Human Blood by Radioimmunoassay

1973 • 64 citations

The Measurement of Angiotensin-Converting Enzyme in Subjects Receiving Captopril

1980 • 35 citations

Cited By (0)

Loading...